Cure My Disease

Don't miss your cure!

 Log in / Sign up

CAR-T cell therapy: What's life really like after treatment?

NCT ID NCT04914091

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Feb 02, 2026 · Last updated May 11, 2026 · Updated 16 times

Summary

This study follows 70 adults with a type of blood cancer (diffuse large B-cell lymphoma) who are receiving CAR-T cell therapy. Researchers want to understand how the treatment affects patients' quality of life and what medications they actually use in everyday care. The goal is to gather real-world information, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH CART-CELLS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospices Civils de Lyon -Groupement Hospitalier Sud Service pharmaceutique, Unité de Pharmacie Clinique Oncologique

    RECRUITING

    Pierre-Bénite, 69495, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH CART-CELLS